{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:11:16Z","timestamp":1783937476808,"version":"3.55.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Risk factors associated with erectile dysfunction (ED) that results from recurrent ischemic priapism (RIP) in sickle cell disease (SCD) are incompletely defined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This study aims to determine and compare ED risk factors associated with SCD and non-SCD-related \u201cminor\u201d RIP, defined as having \u22652 episodes of ischemic priapism within the past 6 months, with the majority (&amp;gt;75%) of episodes lasting &amp;lt;5 hours.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a retrospective study of RIP in SCD and non-SCD patients presenting from June 2004 to March 2014 using the International Index of Erectile Function (IIEF), IIEF-5, and priapism-specific questionnaires.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Prevalence rates and risk factor correlations for ED associated with RIP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study was comprised of 59 patients (40 SCD [mean age 28.2\u2009\u00b1\u20098.9 years] and 19 non-SCD [15 idiopathic and four drug-related etiologies] [mean age 32.6\u2009\u00b1\u200911.7 years]). Nineteen of 40 (47.5%) SCD patients vs. four of 19 (21.1%) non-SCD patients (39% overall) had ED (IIEF &amp;lt;26 or IIEF-5\u2009&amp;lt;22) (P\u2009=\u20090.052). SCD patients had a longer mean time-length with RIP than non-SCD patients (P\u2009=\u20090.004). Thirty of 40 (75%) SCD patients vs. 10 of 19 (52.6%) non-SCD patients (P\u2009=\u20090.14) had \u201cvery minor\u201d RIP (episodes regularly lasting \u22642 hours). Twenty-eight of 40 (70%) SCD patients vs. 14 of 19 (73.7%) non-SCD patients had weekly or more frequent episodes (P\u2009=\u20091). Of all patients with very minor RIP, ED was found among 14 of 30 (46.7%) SCD patients vs. none of 10 (0%) non-SCD patients (P\u2009=\u20090.008). Using logistic regression analysis, the odds ratio for developing ED was 4.7 for SCD patients, when controlling for RIP variables (95% confidence interval: 1.1\u201321.0).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>ED is associated with RIP, occurring in nearly 40% of affected individuals overall. SCD patients are more likely to experience ED in the setting of \u201cvery minor\u201d RIP episodes and are five times more likely to develop ED compared with non-SCD patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jsm.12816","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T11:28:59Z","timestamp":1420802939000},"page":"713-719","source":"Crossref","is-referenced-by-count":52,"title":["Erectile Dysfunction after Sickle Cell Disease\u2013Associated Recurrent Ischemic Priapism: Profile and Risk Factors"],"prefix":"10.1093","volume":"12","author":[{"given":"Uzoma A.","family":"Anele","sequence":"first","affiliation":[{"name":"Department of Urology , Baltimore, MD , USA"},{"name":"The James Buchanan Brady Urological Institute , Baltimore, MD , USA"},{"name":"School of Medicine , Baltimore, MD , USA"},{"name":"The Johns Hopkins University , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[{"name":"Department of Urology , Baltimore, MD , USA"},{"name":"The James Buchanan Brady Urological Institute , Baltimore, MD , USA"},{"name":"School of Medicine , Baltimore, MD , USA"},{"name":"The Johns Hopkins University , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,1]]},"reference":[{"issue":"5 suppl","key":"2023010709205525400_bb0010","first-page":"S39","article-title":"Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism","volume":"13","author":"Berger","year":"2001","journal-title":"Int J Impot Res"},{"key":"2023010709205525400_bb0015","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J Urol"},{"key":"2023010709205525400_bb0020","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archinte.1980.00330220022011","article-title":"Priapism and impotence in homozygous sickle cell disease","volume":"140","author":"Emond","year":"1980","journal-title":"Arch Intern Med"},{"key":"2023010709205525400_bb0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/aja.2012.83","article-title":"A pathophysiology-based approach to the management of early priapism","volume":"15","author":"Kovac","year":"2013","journal-title":"Asian J Androl"},{"key":"2023010709205525400_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1743-6109.2011.02317.x","article-title":"Priapism and sickle-cell anemia: Diagnosis and nonsurgical therapy","volume":"9","author":"Broderick","year":"2012","journal-title":"J Sex Med"},{"key":"2023010709205525400_bb0035","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.eururo.2008.09.044","article-title":"The immediate insertion of a penile prosthesis for acute ischaemic priapism","volume":"56","author":"Ralph","year":"2009","journal-title":"Eur Urol"},{"key":"2023010709205525400_bb0040","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1046\/j.1464-410X.2002.03058.x","article-title":"The management of low-flow priapism with the immediate insertion of a penile prosthesis","volume":"90","author":"Rees","year":"2002","journal-title":"BJU Int"},{"key":"2023010709205525400_bb0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications\u2014An international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int"},{"key":"2023010709205525400_bb0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-5347(17)45549-2","article-title":"The ultrastructure of the erectile tissue in priapism","volume":"135","author":"Spycher","year":"1986","journal-title":"J Urol"},{"key":"2023010709205525400_bb0055","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1743-6109.2006.00333.x","article-title":"Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism","volume":"3","author":"Burnett","year":"2006","journal-title":"J Sex Med"},{"key":"2023010709205525400_bb0060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0090-4295(99)00099-0","article-title":"Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function","volume":"54","author":"Cappelleri","year":"1999","journal-title":"Urology"},{"key":"2023010709205525400_bb0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"key":"2023010709205525400_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1743-6109.2012.02885.x","article-title":"Standard operating procedure for the preservation of erectile function outcomes after radical prostatectomy","volume":"10","author":"Mulhall","year":"2013","journal-title":"J Sex Med"},{"key":"2023010709205525400_bb0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1743-6109.2005.00164.x","article-title":"The correlation between erectile function and patient satisfaction","volume":"4","author":"Teloken","year":"2007","journal-title":"J Sex Med"},{"key":"2023010709205525400_bb0080","article-title":"Predictive factors for return of erectile function in robotic radical prostatectomy: Case series from a single centre","author":"Garcia","year":"2014","journal-title":"Int J Impot Res"},{"key":"2023010709205525400_bb0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1464-4096.2001.01510.x","article-title":"Low-flow priapism: Risk factors for erectile dysfunction","volume":"89","author":"El-Bahnasawy","year":"2002","journal-title":"BJU Int"},{"key":"2023010709205525400_bb0090","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0407183102","article-title":"Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism","volume":"102","author":"Champion","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023010709205525400_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1743-6109.2011.02288.x","article-title":"New insights into the pathophysiology of sickle cell disease-associated priapism","volume":"9","author":"Bivalacqua","year":"2012","journal-title":"J Sex Med"},{"key":"2023010709205525400_bb0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11934-006-0061-6","article-title":"Priapism: New concepts in the pathophysiology and new treatment strategies","volume":"7","author":"Bivalacqua","year":"2006","journal-title":"Curr Urol Rep"},{"key":"2023010709205525400_bb0105","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.urology.2010.02.050","article-title":"Attenuated RhoA\/Rho-kinase signaling in penis of transgenic sickle cell mice","volume":"76","author":"Bivalacqua","year":"2010","journal-title":"Urology"},{"key":"2023010709205525400_bb0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1745-7262.2008.00314.x","article-title":"Insights of priapism mechanism and rationale treatment for recurrent priapism","volume":"10","author":"Yuan","year":"2008","journal-title":"Asian J Androl"},{"key":"2023010709205525400_bb0115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.22195","article-title":"Sickle cell anemia and vascular dysfunction: The nitric oxide connection","volume":"224","author":"Akinsheye","year":"2010","journal-title":"J Cell Physiol"},{"key":"2023010709205525400_bb0120","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"2023010709205525400_bb0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ijir.2010.27","article-title":"Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue","volume":"22","author":"Kanika","year":"2010","journal-title":"Int J Impot Res"},{"key":"2023010709205525400_bb0130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","article-title":"Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis","volume":"189","author":"Lagoda","year":"2013","journal-title":"J Urol"},{"key":"2023010709205525400_bb0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1096\/fj.13-228817","article-title":"Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism","volume":"28","author":"Lagoda","year":"2014","journal-title":"FASEB J"},{"key":"2023010709205525400_bb0140","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0090-4295(03)00484-9","article-title":"Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism","volume":"62","author":"Munarriz","year":"2003","journal-title":"Urology"},{"key":"2023010709205525400_bb0145","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1440-1681.2007.04639.x","article-title":"Sickle cell disease: Role of reactive oxygen and nitrogen metabolites","volume":"34","author":"Wood","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2023010709205525400_bb0150","doi-asserted-by":"crossref","first-page":"e68028","DOI":"10.1371\/journal.pone.0068028","article-title":"Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress","volume":"8","author":"Bivalacqua","year":"2013","journal-title":"PLoS ONE"},{"key":"2023010709205525400_bb0155","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.urology.2005.11.045","article-title":"Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism","volume":"67","author":"Burnett","year":"2006","journal-title":"Urology"},{"key":"2023010709205525400_bb0160","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2014.03.019","article-title":"Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease","volume":"127","author":"Burnett","year":"2014","journal-title":"Am J Med"},{"key":"2023010709205525400_bb0165","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1743-6109.2008.00770.x","article-title":"Sickle cell disease status and outcomes of African-American men presenting with priapism","volume":"5","author":"Bennett","year":"2008","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515309668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515309668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/3\/713\/48475418\/jsm_12_3_713.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/12\/3\/713\/48475418\/jsm_12_3_713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T09:21:26Z","timestamp":1673083286000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/12\/3\/713\/6966657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,1]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,1]]},"published-print":{"date-parts":[[2015,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12816","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,3]]},"published":{"date-parts":[[2015,3,1]]}}}